How Can Registries Contribute to the Development and Evaluation of CNS...
by Joanne B. Severe, MS, and Annette Stemhagen, DrPH, FISPE Ms. Severe is a research consultant in Rockville, Maryland, and Dr. Stemhagen is with United Biosource Corp. in Bethesda, Maryland. Innov...
View ArticleStudy Site Experiences and Attitudes Toward Prospective Assessments of...
by Michelle Stewart, PhD; Adam Butler, PhD; Larry Alphs, MD, PhD; Phillip B. Chappell, MD; Douglas E. Feltner, MD; William R. Lenderking, PhD; Atul R. Mahableshwarkar, MD; Clare W. Makumi, PharmD, MBA;...
View ArticleDefining a Clinically Meaningful Effect for the Design and Interpretation of...
by Richard S. E. Keefe, PhD; Helena C. Kraemer, PhD; Robert S. Epstein, MD, MS; Ellen Frank, PhD; Ginger Haynes, PhD; Thomas P. Laughren, MD; James McNulty, AbScB; Shelby D. Reed, PhD; Juan Sanchez,...
View ArticleClik here to view.
Abstracts of Poster Presentations CNS Summit 2013
November 14–17, 2013 Boca Raton, Florida Innov Clin Neurosci. 2013;10(11–12 Suppl B):1–18The content you are trying to view is restricted to registered members only. Membership to Innovations in...
View ArticleSupplemental Materials to September-October 2014 Issue
S-STS_Pediatric_Version Appendices_A-F S-STS_Update_Appendices_A-H Chappell et al Pharmaceutical Sponsor Survey Chappell et al Supplemental Tables
View ArticleTaking Personalized Medicine Seriously: Biomarker Approaches in Phase IIb/III...
by Harald Murck, MD, PhD; Thomas Laughren, MD; Femke Lamers, PhD; Rosalind Picard, ScD; Sebastian Walther, MD; Donald Goff, MD; and Stephen Sainati, MD, PhD Dr. Murck is with Acorda Therapeutics in...
View ArticleLessons Learned and Potentials for Improvement in CNS Drug Development: ISCTM...
by Steven T. Szabo, MD, PhD; Bruce J. Kinon, MD; Stephen K. Brannan, MD; Andrew K. Krystal, MD, MSc; Joop M A van Gerven, MD, PhD; Atul Mahableshwarkar, MD; and Gary S. Sachs, MD Dr. Szabo is with Duke...
View ArticleTranslational and Early Phase Strategies for Treatment Development: Report of...
by Jared W. Young, PhD; William Z. Potter, MD, PhD; Steve Riley, PharmD, PhD; Geert J. Groeneveld, MD, PhD; Bruce J. Kinon, MD; Mike F. Egan, MD; and Douglas E. Feltner, MD Dr. Young is with the...
View ArticleClik here to view.
Supplement to May–June 2015 Issue: CNS Summit 2014 Abstracts of Poster...
Innov Clin Neurosci. 2015;12(5–6 Suppl B):3–19 Click here to access the e-Edition, a digital replica of the printed version. CNS Drug Compounds/Therapies/Devices Long-acting injectable antipsychotics...
View Article
